Brian O'Connell

The U.S. Food and Drug Administration's laborious and lengthy approval process is hitting healthcare business owners in the pocketbook. But the FDA could be hitting consumers worse.

Finally, the U.S. Food and Drug Administration is getting around to regulating mobile health applications. It's early in the game, but what do the new rules look like?

Academia is getting ever more aggressive about helping entrepreneurs get a running start. An emerging crown jewel could well be Stanford University's brand new StartX.

Can "boom and bust" cycles exist in the venture funding market? You bet they can. And recent data from the chemical sector is a great example of how and why.

In a venture funding climate seeking large returns, thousands of potentially successful entrepreneurial startups can't get the financing they need to make a difference in the economy and in the culture. The problem isn't a new one, but it is a damaging one.

How can healthcare CEOs train the next generation of company leaders? One study suggests training is best done with a healthy dose of no-nonsense straight talk in a one-on-one setting.

There's stability and then there's outright growth. For healthcare business owners looking for angel funding, they'll have to accept the former and wait some more on the latter. But at least it's progress.

If this really is the "new abnormal," entrepreneurs have to change their ways. In a profession where "adapt or die" isn't just a motto, change isn’t a luxury - it's a necessity.

Making new medical discoveries is the lifeblood of the healthcare startup world. That's why the National Institutes of Health wants to lend a hand with a new training program for tomorrow's research geniuses.

Going global is on the wish list of many U.S. entrepreneurs, especially given the sour American economy. But how to go about it? One leading venture capitalist offers some clues.